Medical News

RSS

Oxford Gene Technology launches Cytocell FISH probe for bladder cancer

Oxford Gene Technology (OGT), The Molecular Genetics Company, has launched its CE-IVD labelled Cytocell Aquarius® P16/3c/7c/17c Probe Kit, a cost-effective, ready-to-use fluorescence in situ hybridisation (FISH) probe kit for non-invasive detection of bladder cancer — for sale in Europe.

From Oxford Gene Technology 6 Oct 2015

New UV-Vis spectrophotometer simplifies sample quality decisions

Life scientists who work with DNA, RNA and proteins can make educated decisions about sample suitability in experiments using a standalone, microvolume spectrophotometer for accurate quantitation and purity measurements to ensure downstream application success.

From Thermo Fisher Scientific Inc. 6 Oct 2015

Michigan researchers use Raman spectroscopy to study various childhood diseases

Renishaw, a world leader in metrology and spectroscopy, reports on the use of its inVia confocal Raman microscope in the study of various diseases–with a major focus on childhood diseases–at the Children's Hospital of Michigan and Wayne State University.

6 Oct 2015

Cabozantinib, nivolumab ‘bring hope’ for advanced RCC patients

Clinical trial results suggest significant benefits with the use of cabozantinib or nivolumab over everolimus for patients with advanced renal cell carcinoma, researchers reported at the European Cancer Congress in Vienna, Austria.

6 Oct 2015

Genetic carrier screening: an interview with Don Hardison, CEO of Good Start Genetics

Carrier screening provides you and your doctor with information about your risks of having a child with a serious genetic disease prior to or during pregnancy.

6 Oct 2015

VHI publishes Compare HMOs report to help consumers choose HMOs that meet their needs

What's important to you and your family for health care may be different for your neighbors or co-workers. Virginia Health Information published their Compare HMOs report to help consumers find, compare and choose the HMO that best meets their needs. Compare HMOs is part of VHI's free Consumer Guide to Health Insurance Options, a comprehensive guide helping Virginia consumers and employers learn about health insurance options.

6 Oct 2015

Tarix Orphan's TXA127 granted FDA Fast Track Designation for treatment of DMD patients

Tarix Orphan LLC, a privately held biopharmaceutical company focused on the treatment of rare neuromuscular disorders and connective tissue diseases, today announced that the U.S. Food and Drug Administration has granted Fast Track Designation to TXA127 (angiotensin 1-7) to reduce skeletal muscle damage and fibrosis and thereby improve muscle strength in Duchenne Muscular Dystrophy (DMD) patients.

6 Oct 2015

Vertera Spine receives FDA 510(k) clearance for COHERE Cervical Interbody Fusion Device

Vertera Spine, a developer of medical devices with advanced functional surface technologies for spine applications, today announced it has received U.S. Food and Drug Administration 510(k) clearance for its COHERE Cervical Interbody Fusion Device.

6 Oct 2015

First patients screened in Axovant's phase 3 study of RVT-101

Axovant Sciences Ltd., a leading clinical-stage biopharmaceutical company focused on the treatment of dementia, today announced the first patients screened in MINDSET, a confirmatory global phase 3 study of Axovant's lead product candidate, RVT-101. Axovant also announced that the company and the U.S. Food and Drug Administration have agreed to a Special Protocol Assessment (SPA) supporting this phase 3 program.

6 Oct 2015

AcelRx Pharmaceuticals initiates ARX-04 Phase 3 study in emergency room patients with acute pain

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute and breakthrough pain, today announced the initiation of an open-label Phase 3 study (SAP302) of ARX-04 for the treatment of adult patients who present in the emergency room with moderate-to-severe acute pain associated with trauma or injury.

6 Oct 2015

Epilepsy Society becomes third customer of Complete Genomics' newly introduced Revolocity system

Complete Genomics, Inc., a leader in whole human genome sequencing, announced today that leading UK charity Epilepsy Society has become the third customer of the company's newly introduced Revolocity system, a supersequencer for large-scale, high-quality whole genome and whole exome sequencing.

6 Oct 2015

Envisia's ENV515 (travoprost XR) meets primary efficacy endpoint in phase 2a glaucoma trial

Envisia Therapeutics, a clinical-stage biotechnology company focused on the development of novel extended-release therapies in ophthalmology, today reported results from its first clinical trial of the Company's lead product candidate, ENV515 (travoprost XR).

6 Oct 2015

2e Creative named Medical Marketing & Media's 2015 Small Healthcare Agency of the Year

2e Creative, Inc., a full-service creative agency based in St. Louis, Mo., focused on healthcare, science, and technology, was recently named Medical Marketing & Media's "2015 Small Healthcare Agency of the Year." This award marks back-to-back Agency of the Year wins for 2e Creative, who was named "Healthcare Impact Agency of the Year" by Advertising Age and Modern Healthcare in 2014.

6 Oct 2015

Acetaminophen Awareness Coalition issues safety message to consumers about flu medicines

With cold and flu season around the corner, consumers will soon begin to purchase medicines such as cough syrup, throat lozenges, and nasal sprays to help get relief from symptoms such as fever, coughs, congestion, and more. Many of the medicines used to treat these cold and flu symptoms can contain common drug ingredients such as acetaminophen.

6 Oct 2015

Mycobacterium could be more effective in treating superficial bladder cancer, study finds

Universitat Autònoma de Barcelona researchers have found a mycobacterium that is more effective in treating superficial bladder cancer and does not cause infections, unlike those used up to now.

6 Oct 2015

Dopamine transmission mediated by D1 receptors essential for controlling movements in Parkinson's disease

Dopamine deficiency in the basal ganglia (a set of subcortical structures) causes severe motor dysfunctions, such as slowness of movements (bradykinesia), as observed in Parkinson's disease. Dopamine binds D1 and D2 receptors that are expressed in the nerve cells of the striatum (a structure of the basal ganglia), and exerts different effects on the nerve cells. However, how dopamine controls through these receptors the information flow in the basal ganglia and voluntary movements is still not clear.

6 Oct 2015

Getting right nutrition throughout life can help protect against osteoporosis in old age

Whether you're young or old, the right nutrition can make a difference to your bone health and influence your ability to live an independent, mobile, fracture-free life into your more senior years. That's the key message of a new scientific review published today in the journal 'Osteoporosis International' by leading bone and nutrition experts, in anticipation of World Osteoporosis Day on October 20.

6 Oct 2015

Cost effectiveness, health benefits of implementing rebate program for low-income households

Providing low-income households that receive federal food assistance benefits with financial incentives to buy fruits and vegetables would encourage them to purchase and consume more healthy food, and slightly increase their longevity, a new study suggests.

6 Oct 2015

Big data predictive analytic methods may help identify soldiers at high risk for committing violent crimes

Workplace violence perpetrated by military personnel is a major concern of the U.S. Department of Defense. Although programs have been implemented to teach violence prevention strategies to all military personnel, such programs are much less intensive than others developed in settings for people judged to be at high risk of violent behavior.

6 Oct 2015

Training ASD individuals by repetition actually harms learning ability

Individuals with autism spectrum disorder (ASD) sometimes acquire a new behavior or skill only in a specific context, but they have difficulty transferring that learned skill or information to a new context.

6 Oct 2015

Medical News

Oxford Gene Technology launches Cytocell FISH probe for bladder cancer

New UV-Vis spectrophotometer simplifies sample quality decisions

Michigan researchers use Raman spectroscopy to study various childhood diseases

Cabozantinib, nivolumab ‘bring hope’ for advanced RCC patients

Genetic carrier screening: an interview with Don Hardison, CEO of Good Start Genetics

VHI publishes Compare HMOs report to help consumers choose HMOs that meet their needs

Tarix Orphan's TXA127 granted FDA Fast Track Designation for treatment of DMD patients

Vertera Spine receives FDA 510(k) clearance for COHERE Cervical Interbody Fusion Device

First patients screened in Axovant's phase 3 study of RVT-101

AcelRx Pharmaceuticals initiates ARX-04 Phase 3 study in emergency room patients with acute pain

Epilepsy Society becomes third customer of Complete Genomics' newly introduced Revolocity system

Envisia's ENV515 (travoprost XR) meets primary efficacy endpoint in phase 2a glaucoma trial

2e Creative named Medical Marketing & Media's 2015 Small Healthcare Agency of the Year

Acetaminophen Awareness Coalition issues safety message to consumers about flu medicines

Mycobacterium could be more effective in treating superficial bladder cancer, study finds

Dopamine transmission mediated by D1 receptors essential for controlling movements in Parkinson's disease

Getting right nutrition throughout life can help protect against osteoporosis in old age

Cost effectiveness, health benefits of implementing rebate program for low-income households

Big data predictive analytic methods may help identify soldiers at high risk for committing violent crimes

Training ASD individuals by repetition actually harms learning ability

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News